Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer

British Journal of Cancer

Volumn 109, Issue 1, 2013, Pages 131-137

  Guthrie, G J K ^a   Roxburgh, C S D ^a   Richards, C H ^a   Horgan, P G ^a   McMillan, D C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; VASCULOTROPIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CANCER PROGNOSIS; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTRAABDOMINAL FAT; LEUKOCYTE DIFFERENTIAL COUNT; LOCAL INFLAMMATORY RESPONSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MODIFIED GLASGOW PROGNOSTIC SCORE; MUSCLE MASS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUTROPHIL COUNT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; SYSTEMIC INFLAMMATORY RESPONSE; THROMBOCYTE COUNT; TUMOR NECROSIS;

AGED; BODY COMPOSITION; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; NECROSIS; NEUTROPHILS; PLATELET COUNT; SERUM ALBUMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880286579     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.291     Document Type: Article

References (42)

1. AJCC (2010) Colon and Rectum Cancer Staging. AJCC Cancer Staging Manual. AJCC Cancer Staging Manual. 7th edition.
2. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R, Jalkanen S (2012) Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 131: 864-873.
3. Argiles JM, Busquets S, Lopez-Soriano FJ (2005) The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 37: 2036-2046.
4. Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, Koniaris LG, Zimmers TA (2012) JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 303: E410-E421.
5. CancerStats (2005-2010) http://www.cancerresearchuk.org.
6. Chua W, Charles KA, Baracos VE, Clarke SJ (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104: 1288-1295.
7. De Vita F, O. M, Galizia G, Romano C, Lieto E, Iodice P, Tuccillo C, Catalano G (2000) Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep 7: 357-418.
8. Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, Palmqvist R (2012) The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7: e47045.
9. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13: 1472-1479.
10. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
11. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, Mcmillan DC, Clarke SJ (2013a) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol; e-pub ahead of print 16 April 2013; doi: 10.1016/j.critrevonc.2013.03.010.
12. Guthrie GJ, Mcmillan DC (2013) Comment on 'Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma'. Br J Cancer 108: 1915-1916.
13. Guthrie GJ, Roxburgh CS, Horgan PG, Mcmillan DC (2013b) Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev 39: 89-96.
14. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
15. Herbeuval J-P, Lelievre E, Lambert C, Dy M, Genin C (2004) Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J Immunol 172: 4630-4636.
16. Hsu CP, Chung YC (2006) Influence of interleukin-6 on the invasiveness of human colorectal carcinoma. Anticancer Res 26: 4607-4614.
17. Kantola T, Klintrup K, Vayrynen JP, Vornanen J, Bloigu R, Karhu T, Herzig KH, Napankangas J, Makela J, Karttunen TJ, Tuomisto A, Makinen MJ (2012) Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 107: 1729-1736.
18. Kinouchi M, Miura K, Mizoi T, Ishida K, Fujibuchi W, Sasaki H, Ohnuma S, Saito K, Katayose Y, Naitoh T, Motoi F, Shiiba KI, Egawa S, Shibata C, Unno M (2012) Infiltration of CD40-positive tumor-associated macrophages indicates a favorable prognosis in colorectal cancer patients. Hepatogastroenterology 60(121); e-pub ahead of print 8 June 2013; doi: 10.5754/hge12372.
19. Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, Tuominen H, Tuppurainen K, Makela J, Karttunen TJ, Makinen MJ (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41: 2645-2654.
20. Lackner C, Jukic Z, Tsybrovskyy O, Jatzko G, Wette V, Hoefler G, Klimpfinger M, Denk H, Zatloukal K (2004) Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch 445: 160-167.
21. Laoui D, Van Overmeire E, Movahedi K, Van Den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, de Baetselier P, Van Ginderachter JA (2011) Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology 216: 1192-1202.
22. Lee JK, Bettencourt R, Brenner D, LE TA, Barrett-Connor E, Loomba R (2012) Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study. PLoS One 7: e34218.
23. Lieubeau B, Heymann MF, Henry F, Barbieux I, Meflah K, Gregoire M (1999) Immunomodulatory effects of tumor-associated fibroblasts in colorectaltumor development. Int J Cancer 81: 629-636.
24. Mcmillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39: 534-540.
25. Mocellin S, Marincola FM, Young HA (2005) Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78: 1043-1051.
26. Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, Mcmillan DC (2012) The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer 107: 864-873.
27. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van Den Bossche J, Mack M, Pipeleers D, In't Veld P, De Baetselier P, Van Ginderachter JA (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70: 5728-5739.
28. Oliphant R, Nicholson G, Horgan P, Molloy R, Mcmillan D, Morrison D (2013) Deprivation and colorectal cancer surgery: longer-term survival inequalities are due to differential postoperative mortality between socioeconomic groups. Ann Surg Oncol 1-8.
29. Piancatelli D, Romano P, Sebastiani P, Adorno D, Casciani CU (1999) Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother 22: 25-32.
30. Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, Langner C (2010) Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol 41: 1749-1757.
31. Richards CH, Flegg KM, Roxburgh CS, Going JJ, Mohammed Z, Horgan PG, Mcmillan DC (2012a) The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. Br J Cancer 106: 2010-2015.
32. Richards CH, Roxburgh CS, Anderson JH, Mckee RF, Foulis AK, Horgan PG, Mcmillan DC (2012b) Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg 99: 287-294.
33. Richards CH, Roxburgh CS, Macmillan MT, Isswiasi S, Robertson EG, Guthrie GK, Horgan PG, Mcmillan DC (2012c) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One 7: e41883.
34. Richards DM, Hettinger J, Feuerer M (2012d) Monocytes and macrophages in cancer: development and functions. Cancer Microenviron. e-pub ahead of print 24 November 2012.
35. Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D (2007) The IL-6/ sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11: 613-624.
36. Roxburgh CS, Mcmillan DC (2012) The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 38: 451-466.
37. Scheller J, Ohnesorge N, Rose-John S (2006) Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63: 321-329.
38. Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717-727.
39. Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86: 1065-1073.
40. Strassmann G, FongM, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89: 1681-1684.
41. Trikha M, Corringham R, Klein B, Rossi JF (2003) Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 9: 4653-4665.
42. Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, Zeng YX, Zhang XS (2010) The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 8: 13.